682-P: Novel Dual Glucagon and Glucagon-Like Peptide-1 Receptor Agonist LY3305677 Improves Glucose Control, Reduces Body Weight, and Increases Energy Expenditure in Mice

内科学 内分泌学 胰高血糖素 胰高血糖素样肽-1 胰岛素 兴奋剂 胰高血糖素受体 受体 2型糖尿病 医学 化学 生物 糖尿病
作者
Yanyun Chen,Adam R. Mezo,Tamer Coşkun,Min Song,William C. Roell,Krister Bokvist,Julie S. Moyers,Melissa K. Thomas,Francisco Valenzuela,Hongchang Qu
出处
期刊:Diabetes [American Diabetes Association]
卷期号:70 (Supplement_1) 被引量:11
标识
DOI:10.2337/db21-682-p
摘要

LY3305677 (LY) is a synthetic peptide analog of mammalian oxyntomodulin with a fatty acyl side chain to extend time action. LY functions are mediated by binding and activation of both glucagon (GcgR) and glucagon-like peptide-1 (GLP-1R) receptors. LY is bound with potent binding affinity (Ki) to human and mouse GcgR (Ki: 17.7 nM and 15.9 nM, respectively) and GLP-1R (Ki: 28.6 nM and 25.1 nM, respectively). LY dose-dependently stimulated insulin secretion in mouse pancreatic islets (EC50: 5.2 nM) and in mice. In oral glucose tolerance tests of diet-induced obese (DIO) and streptozotocin-induced diabetic mice, a single subcutaneous (SC) dose of LY significantly reduced glucose area under the curve by up to 65%. SC injections of LY to DIO mice dose-dependently reduced serum triglycerides and PCSK9 (proprotein convertase subtilisin/kexin type 9) levels and dose-dependently increased FGF21 (fibroblast growth factor 21) levels. In DIO mice treated over 18 days, LY 30 nmol/kg reduced body weight to a greater extent (33%) than semaglutide 60 nmol/kg (12%), and decreased food intake by 50% compared to vehicle. At Day 18, LY 30 nmol/kg group lost 33% of initial bodyweight, which was primarily due to 70% reduced fat mass. LY reduced liver triglycerides by greater than 70% and increased serum ketones by more than 3-fold compared to vehicle, suggestive of increased fatty acid oxidation. LY decreased body weight in both GcgR knock-out (KO) and GLP-1R KO mice, indicating that activation of both receptors contributed to greater weight loss. To assess potential changes in energy expenditure, DIO mice were treated chronically with SC LY (15 nmol/kg), semaglutide (60 nmol/kg), or vehicle. LY, but not semaglutide, increased energy expenditure as compared with vehicle. These preclinical studies indicate that novel dual GcgR and GLP-1R agonist LY may have potential to enhance metabolic health by improving dyslipidemia, hyperglycemia, or obesity. Disclosure Y. Chen: None. H. Qu: Employee; Self; Eli Lilly and Company, Stock/Shareholder; Self; Eli Lilly and Company. A. Mezo: None. T. Coskun: Employee; Self; Eli Lilly and Company, Stock/Shareholder; Self; Eli Lilly and Company. M. Song: None. W. C. Roell: Employee; Self; Eli Lilly and Company, Stock/Shareholder; Self; Eli Lilly and Company. K. B. Bokvist: Employee; Self; Eli Lilly and Company, Sanofi-Aventis Deutschland GmbH, Stock/Shareholder; Self; Johnson & Johnson, Sanofi-Aventis Deutschland GmbH, Stock/Shareholder; Spouse/Partner; Novo Nordisk A/S. J. S. Moyers: Employee; Self; Eli Lilly and Company, Stock/Shareholder; Self; Eli Lilly and Company. M. K. Thomas: Employee; Self; Eli Lilly and Company, Stock/Shareholder; Self; Eli Lilly and Company. F. Valenzuela: None. Funding Eli Lilly and Company
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Sidney完成签到 ,获得积分10
刚刚
1秒前
酷炫小甜瓜完成签到 ,获得积分10
1秒前
学阿斗完成签到,获得积分10
1秒前
迷路的忆之完成签到,获得积分10
1秒前
锂离子发布了新的文献求助10
2秒前
liuzhanyu发布了新的文献求助30
3秒前
4秒前
5秒前
知性的藏鸟完成签到 ,获得积分10
5秒前
华圣拿下巨蜥完成签到,获得积分10
6秒前
7秒前
8秒前
大力的可乐完成签到,获得积分10
9秒前
echowang完成签到,获得积分10
9秒前
小蘑菇的应助被zenghong采纳,获得10
11秒前
12秒前
华仔的应助被daipeng采纳,获得10
13秒前
三语掾发布了新的文献求助10
13秒前
昕昕233发布了新的文献求助10
13秒前
可爱的函函的应助被dangdindong采纳,获得10
15秒前
雪中漫步发布了新的文献求助10
16秒前
执着新竹完成签到,获得积分10
16秒前
房同学完成签到,获得积分10
16秒前
16秒前
橘子味完成签到 ,获得积分10
17秒前
赵云发布了新的文献求助10
17秒前
海边烤苞米完成签到,获得积分10
17秒前
yy32323完成签到,获得积分10
18秒前
18秒前
独特的追命完成签到,获得积分10
19秒前
Ingrid完成签到,获得积分10
20秒前
凉拌西红柿完成签到,获得积分10
21秒前
ZY完成签到 ,获得积分10
21秒前
小升初完成签到,获得积分10
22秒前
yipmyonphu的应助被独特的追命采纳,获得50
22秒前
彭于晏的应助被袁志阳采纳,获得10
22秒前
yang发布了新的文献求助10
23秒前
小巧妙梦发布了新的文献求助10
23秒前
星辰大海的应助被凑凑采纳,获得10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186819
求助须知:如何正确求助?哪些是违规求助? 9575195
关于积分的说明 21839872
捐赠科研通 7784526
什么是DOI,文献DOI怎么找? 3434849
关于科研通互助平台的介绍 2559266
邀请新用户注册赠送积分活动 2481716